Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1993
11/18/1993EP0313569B1 Enhancement of the cellular immune response
11/17/1993CN1078400A Method for reducing side effects of a drug
11/17/1993CN1078388A Treatment of disease employing hyuluronic acid and NSAIDS
11/16/1993US5262436 Acylamino acid antihypertensives in the treatment of congestive heart failure
11/16/1993US5262419 Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
11/16/1993US5262319 Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
11/16/1993US5262164 Insertion into or around the tooth cavity the drug monolein mixed with vitamins, antiiinflammatory agents, antibiotics, peroxides, anesthetic agents and microbactericides
11/11/1993WO1993022685A1 Evaluative means for detecting inflammatory reactivity
11/11/1993WO1993021992A1 Laser treatment
11/11/1993WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993WO1993021927A1 Minimizing progestin associated breakthrough bleeding
11/11/1993WO1993021926A1 Minimizing progestin associated breakthrough bleeding
11/11/1993WO1993021924A1 Drug for increasing the level of testosterone in the body
11/11/1993WO1993021920A1 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
11/11/1993WO1993021916A1 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
11/11/1993WO1993021901A1 Galenic form for ocular administration and process for the preparation of same
11/11/1993WO1993021859A1 Tissue-specific implantable therapeutic agent delivery system
11/11/1993WO1993017691A3 Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease
11/11/1993DE4214953A1 Arzneimittel zur Erhöhung des Testosteronspiegels Medicines to increase testosterone levels
11/11/1993CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/10/1993EP0569042A1 Medical uses of IL-1 beta
11/10/1993EP0552302A4 Method of inhibiting transcription utilizing nuclear receptors
11/10/1993EP0376986A4 Chemical splinter removal
11/09/1993US5260322 Angiotension II antagonists in the treatment of hyperuricemia
11/09/1993US5260210 Blood-brain barrier model
11/09/1993CA1324077C Additives enhancing topical actions of therapeutic agents
11/03/1993EP0567613A1 Compositions and methods for therapy and prevention of cancer, aids, and anemia
11/03/1993CN1077887A Compositions of clindamycin and benzoyl peroxide for acne treatment
10/1993
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021229A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
10/28/1993WO1993021193A1 Platinum complex and antineoplastic agent
10/28/1993WO1993020839A2 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
10/28/1993WO1993020823A1 Ocular androgen therapy in sjögren's syndrome
10/28/1993WO1993020822A1 Compositions of platelet activating factor antagonists and methods of treating interleukin-2 induced lung injury therewith
10/28/1993WO1993020816A1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
10/28/1993WO1993020815A1 Use of h-2 antagonists for treatment of gingivitis
10/28/1993WO1993020718A1 Food composition which inhibits formation of intestinal putrefaction product
10/28/1993WO1993020696A1 Regulation of the immune system
10/28/1993WO1993018762A3 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
10/28/1993CA2133754A1 Compositions of platelet activating factor antagonists and methods of treating interleukin-2 induced lung injury therewith
10/28/1993CA2118217A1 Platinum complex and antitumor agent
10/27/1993EP0425659B1 SUSTAINED RELEASE PHARMACEUTICAL PREPARATIONS HAVING pH CONTROLLED MEMBRANE COATINGS
10/27/1993EP0191824B1 Encapsulation of antineoplastic agents in liposomes
10/27/1993EP0190315B1 Dehydrated liposomes
10/26/1993US5256691 Oil-in-water type emulsified composition comprising non-steroidal antiphlogistic and analgesic drug
10/26/1993US5256684 Methods and compositions for the treatment of gastrointestinal disorders
10/26/1993CA2033975C Use of .beta.-receptor blocking agents
10/20/1993EP0566542A1 Use of L-carnitine or acyl-L-carnitine in combination with an ACE-inhibitor for producing pharmaceutical composition for the treatment of cardiovascular disorders
10/20/1993EP0566157A1 Neutral metalloendopeptidase inhibitors in the treatment of hypertension
10/20/1993EP0565634A1 Angiotensin ii receptor blocking compositions
10/19/1993US5254587 Methods for treating AIDS
10/19/1993US5254546 Fused aryl substituted imidazole angiotensin II receptor inhibitors
10/19/1993US5254339 Solubilizing antigen; complexing with glycosides containing hydrophobic and hydrophilic domains; isolation; purification
10/19/1993CA1323303C Advanced anticancer therapy and cytotoxic medicaments for its implementation
10/19/1993CA1323294C Method of treatment of central nervous system diseases such as alzheimer's disease and parkinson's disease and method of diagnosing alzheimer's disease
10/14/1993WO1993020082A1 Calanolide antiviral compounds, compositions and uses thereof
10/14/1993WO1993019789A1 Wound dressing, wound plaster or carrier matrix
10/14/1993WO1993019758A1 Compositions and methods for treating benign prostatic hypertrophy
10/14/1993WO1993019742A1 Medicament against cardiac circulatory diseases
10/14/1993WO1993019731A1 Skin care method and composition
10/14/1993WO1993019668A1 Method and kit for imaging and treating organs and tissues
10/14/1993WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression
10/14/1993WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated
10/14/1993DE4212122A1 Low calorie food contg. fat, carbohydrate, protein, calcium salt and vitamin=D - is used for prevention of osteoporosis before bone metabolism leads to pronounced loss of bone material
10/14/1993CA2133440A1 Compositions and methods for treating benign prostatic hypertrophy
10/14/1993CA2133085A1 Skin care method and composition
10/13/1993EP0565241A1 Oligosaccharides
10/13/1993EP0353267B1 Emulsion for parenteral administration
10/12/1993US5252471 Directed biosynthesis of cholesterol lowering compounds
10/07/1993DE4242015A1 Wundverband, Wundauflage oder Trägermatrix Dressing, wound overlay or carrier matrix
10/07/1993DE4211239A1 Arzneimittel gegen Herz-Kreislauf-Erkrankungen Medicines for cardiovascular disease
10/06/1993EP0563060A1 Synergism of tnf and il-4
10/06/1993EP0525055A4 Improved iontophoretic administration of drugs
10/05/1993CA1322717C Combination of renal vasodilators and alpha 1-adrenergic or ganglionic blocking agents and methods for treating diseases
09/1993
09/30/1993WO1993018775A1 Method and composition for suppression of side effects of anti-inflammatory drugs
09/30/1993WO1993018772A1 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
09/30/1993WO1993018768A1 Combinations of parasympathomimetic agents with muscarinic antagonists for treating nicotine craving in smoking cessation
09/30/1993WO1993018762A2 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
09/30/1993WO1993018750A1 Method for reducing side-effects of a drug
09/30/1993WO1993018747A1 Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface
09/30/1993CA2132427A1 Method and composition for suppresion of side effects of anti-inflammatory drugs
09/30/1993CA2132209A1 Combinations of parasympathomimetic agents with muscarinic antagonists for treating nicotine craving in smoking cessation
09/30/1993CA2132102A1 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
09/29/1993EP0562853A1 29-Demethoxyrapamycin for inducing immunosuppression
09/29/1993EP0562641A1 Dehydrated liposomes
09/29/1993EP0562508A2 Protein with bone formation ability and process for its production
09/28/1993US5248678 Methods for increasing arousal and alertness and for the amelioration of comatose states
09/28/1993CA2092768A1 Protein with bone formation ability and process for its production
09/28/1993CA2092729A1 Method for inducing immunosuppression
09/28/1993CA1322529C Dosage form of fenofibrate
09/28/1993CA1322527C Compositions and methods of effecting contraception
09/28/1993CA1322526C Chemical prevention or reversal of cataract by phase separation inhibitors
09/28/1993CA1322523C Central nervous system injury treatment with opiate- receptor antagonists
09/28/1993CA1322522C Traumatic and ischemic brain injury treatment with opiate-receptor antagonists
09/23/1993DE4307883A1 Use of anti-retroviral substances - to treat motor-neuronal diseases
09/22/1993EP0561424A1 Dehydrated liposomes
09/22/1993EP0561357A1 Pharmaceutical composition comprising a potassium-channel-opener and an antagonist of angiotensin-II receptors
09/22/1993EP0560989A1 Enteral preparation for cancer therapy
09/22/1993EP0560929A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
09/22/1993CN1076358A Methods and compositions for reducing multi-drug resistance
1 ... 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 ... 1151